Prior authorization (PA) requirements, cost, and other factors can lead to turnaround times of up to 3 weeks, delaying the start of therapy and creating substantial anxiety for patients.
Stuart Deal, PharmD, RPh
Advertisement
Articles by Stuart Deal, PharmD, RPh
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
2
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
3
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
4
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
5